Trial Information
Inclusion Criteria:
- Patients with cT2-T3a prostate cancer
Exclusion Criteria:
- Men>75 years
- Men<18 years
- Prior hormonal therapy
- Prior radiation or chemotherapy
- Prior investigational agents
- Life expectancy > 10 years
- Prior malignancy within the last five years
- Any other serious medical or psychiatric condition
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind
Principal Investigator
Giovanni Luca Gravina, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of L'Aquila
Authority:
Italy: Ethics Committee
Study ID:
SMBC142
NCT ID:
NCT00421694
Start Date:
Completion Date:
Related Keywords:
- Prostate Cancer
- Prostatic Neoplasms